The Mycoplasma Pneumonia theme has 20 member stock(s) today, with an average return of +0.5%. The leading stock is 인트론바이오 (+7.6%, trading value 403,728,329).
Pediatric bacterial pneumonia theme, gaining attention when outbreak alerts trigger reports of surging demand for specific antibiotics and diagnostic kits.
| Stock | Price | Return | Trading Value |
|---|---|---|---|
| 인트론바이오 | 2,900 | +7.6% | 403,728,329 |
| 녹십자엠에스 | 3,220 | +3.7% | 1,254,206,398 |
| 휴마시스 | 2,920 | +3.0% | 144,837,808 |
| 수젠텍 | 4,630 | +2.2% | 2,252,114,706 |
| 씨젠 | 31,950 | +1.3% | 11,143,340,300 |
| 진매트릭스 | 1,600 | +1.1% | 197,188,217 |
| 젠큐릭스 | 1,957 | +0.9% | 327,319,487 |
| 광동제약 | 6,380 | +0.6% | 427,177,810 |
| 경동제약 | 5,090 | +0.2% | 150,760,515 |
| 팜젠사이언스 | 3,030 | +0.2% | 39,765,120 |
| 비씨월드제약 | 3,045 | +0.2% | 19,515,000 |
| 위더스제약 | 7,410 | +0.1% | 2,123,303,190 |
| DXVX | 2,380 | 0.0% | 165,931,645 |
| 엑세스바이오 | 2,470 | -0.2% | 241,902,105 |
| 조아제약 | 2,715 | -0.4% | 111,012,008 |
| 국제약품 | 3,265 | -1.2% | 60,552,190 |
| 국전 | 2,210 | -1.6% | 157,315,655 |
| 멕아이씨에스 | 1,548 | -2.0% | 574,956,359 |
| 씨티씨바이오 | 3,020 | -2.6% | 90,423,020 |
| 미래생명자원 | 2,020 | -3.1% | 403,845,740 |
This page's data is for reference only and is not investment advice. Actual market data may differ.